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Hemophagocytic lymphohistiocytosis—which is associated
with a variety of infections, malignant neoplasms, autoimmune
diseases, and immunodeficiencies—-is an uncommon syn-
drome with a rapidly fatal outcome. We describe the first case
of hemorrhagic fever with renal syndrome due to Hantaan virus
presenting with reactive hemophagocytosis. 
emophagocytic lymphohistiocytosis (HLH) is an uncom-
mon syndrome characterized by a reactive, systemic pro-
liferation of benign histiocytes throughout the reti-
culoendothelial system (1). It is associated with a variety of
infections, malignant neoplasms, drugs, autoimmune diseases,
and various immunodeficiencies. Infection-induced HLH is
often associated with systemic viral infections, particularly
Epstein-Barr virus, and occasionally with bacterial, fungal, or
parasitic infections. For most patients with HLH, the outcome
is rapid and fatal unless the diagnosis is made early and fol-
lowed by prompt therapeutic intervention (1,2).
Hemorrhagic fever with renal syndrome (HFRS), which is
caused by Hantaan, Puumala, Seoul, and Dobrava-Belgrade
viruses (HTNV, PUUV, SEOV, and DOBV, respectively) is
acquired primarily through aerosols of infectious rodent urine
(3). Recently, Baty et al. (4) reported a case of hemophago-
cytic syndrome associated with PUUV, the most common
cause of HFRS in Europe. Our report describes an unusual
case of HFRS caused by HTNV presenting with secondary
hemop-hagocytosis.
Case Report
A 57-year-old woman was admitted to Chonnam National
University Hospital, South Korea, with fatigue, generalized
myalgia, and nausea of 2 weeks’ duration. Three weeks before
admission, she had worked in a field in a rural area. Her vital
signs were blood pressure 140/90 mm Hg, heart rate 80/min,
temperature 36.6°C, and respiratory rate 20/min. On examina-
tion, she appeared acutely ill and had conjunctival suffusion,
petechiae in the throat, an erythematous rash on the chest, ten-
der hepatosplenomegaly, and mild tenderness in both flanks.
There were no palpable lymph nodes.
Her leukocyte count was 3,200/µL, hemoglobin 9.9 g/dL,
platelet count 25,000/µL, and reticulocyte count 0.3%. Blood
chemistry revealed total serum protein 6.3 g/dL, albumin 3.0
g/dL, alkaline phosphatase 174 U/L, aspartate aminotrans-
ferase 369 U/L, alanine aminotransferase 175 U/L, total biliru-
bin 0.6 mg/dL (direct, 0.3 mg/dL), blood urea nitrogen 8.6 mg/
dL, creatinine 0.5 mg/dL, lactic dehydrogenase 2,066 U/L,
total cholesterol 100 mg/dL, HDL-cholesterol 22 mg/dL, trig-
lyceride 285 mg/dL, and ferritin 20,000 µg/L. The coagulation
profile included a prothrombin time of 13.6 seconds (control
12.5 seconds), a partial thromboplastin time of 45.2 seconds
(control from 28 to 40 seconds), and a fibrinogen assay of 120
mg/dL. Serologic tests for viral infections—including antibod-
ies against Epstein-Barr virus, cytomegalovirus, herpes, Hepa-
titis A, B, and C viruses, and HIV—were negative. Serologic
tests for Leptospira and Rickettsia tsutsugamushi and connec-
tive tissue diseases were also negative. HTNV titers using a
particle agglutination kit (HANTADIA, Greencross, Korea)
were 1:160 (normal <1:80). Cultures of blood, urine, and spu-
tum were sterile. A computed tomographic scan of the abdo-
men showed moderate hepatosplenomegaly without
lymphadenopathy. Bone marrow aspirate revealed prolifera-
tion of histiocytes with prominent hemophagocytosis (Figure).
On day 8 of hospitalization, the second serologic titer for
HTNV was elevated at 1:5,120. Fortunately, the patient recov-
ered completely with only supportive care, including aggres-
sive replacement of blood components, over 14 days (Table).
Conclusions
Patients with infection-associated HLH usually have per-
sistent unexplained fever, cytopenia, lymphadenopathy, and,
frequently, hepatosplenomegaly and coagulopathy, causing
diagnostic difficulties with malignant histiocytosis or T-cell
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Figure. Bone marrow aspirate showing phagocytosis of neutrophil,
nucleated erythrocyte, and platelets by benign histiocytes (Wright stain,
x400).DISPATCHES
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lymphoma (2). The possible immunopathologic mechanism of
HLH might be excessive production of Th1 cytokines, such as
gamma-interferon, tumor necrosis factor-alpha, interleukin-1,
or interleukin-6, from activated lymphocytes or monocytes
(1,2). Patients with Epstein-Barr virus-associated HLH (which
if not treated is usually fatal because of hemorrhage, infection,
or multiorgan failure) should initially be treated with a combi-
nation of corticosteroids and chemotherapy (1,2). As with our
case, a patient with reactive HLH associated with organisms
other than Epstein-Barr virus requires supportive care and
treatment of the underlying disease (1,2).
We believe that this is the first case of HFRS caused by
HTNV presenting with HLH. Thus, HFRS caused by HTNV
or PUUV should also be considered as one of the underlying
infectious diseases resulting in hemophagocytosis, requiring
early diagnosis followed by prompt therapeutic intervention.
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Table. Serial laboratory findings in patient with hemorrhagic fever with 
renal syndrome from hospitalization until recovery, Korea
Laboratory test On admission Day 5 Day 8 Day 14
Leukocyte count (/µL) 3,200 3,300 4,100 4,400
Hemoglobin (g/dL) 9.9 10.2 11.4 11.2
Platelet count (/µL) 25,000 31,000 76,000 147,000
AST (U/L) 369 682 108 21
ALT (U/L)
BUN (mg/dL)
Cr (mg/dL)
175
8.6
0.5
433
8.8
0.8
205
8.6
0.7
21
13.6
0.9
Lactic dehydrogenase 
(U/L)
2,066 3,206 1,645 472
Ferritin (µg/L) 20,000 - 860 -
Hantaan virus titer 1:160 - 1:5,120 -
AST = aspartate aminotransferase, ALT = alanine aminotransferase; BUN = blood urea 
nitrogen.